New and Special Drug
-
RYBELSUS (Semaglutide) – T2DM | HongKong DengYue Medicine
-
Vascepa® (Icosapent Ethyl) – Hypertriglyceridaemia | HongKong DengYue Medicine
-
Aixinan (Recaticimab Injection) – Hypercholesterolemia | HongKong DengYue Medicine
-
VITRAKVI (Larotrectinib) – Tumor Agnostic Therapy | HongKong DengYue Medicine
-
Youshiying (Fluocinolone Acetonide Intravitreal Implants) – NIU-PS | HongKong DengYue Medicine
-
Xofluza (Baloxavir Marboxil Tablets) – Influenza | HongKong DengYue Medicine
-
Nucala (Mepolizumab) – Eosinophil Driven | HongKong DengYue Medicine
-
Kaitanni (Cadonilimab Injection) – Oncologic immunotherapy | HongKong DengYue Medicine
-
YuTuo (Zimberelimab Injection) – cHL | HongKong DengYue Medicine
-
Orencia (Abatacept Injection) – Arthritis | HongKong DengYue Medicine
-
Yixining (Ebronucimab Injection) – Hypercholesterolemia | HongKong DengYue Medicine
-
Gazyva (Obinutuzumab) – Follicular Lymphoma | HongKong DengYue Medicine
-
Aidaro (Ebdarokimab) – Psoriasis | HongKong DengYue Medicine
-
Zepsun (Donafenib Tosilate) – HCC | HongKong DengYue Medicine
-
Partruvix (Pamiparib) – gBRCA | HongKong DengYue Medicine
-
Nubeqa (Darolutamide) – Prostate Cancer | HongKong DengYue Medicine
Copyright@ 2016-2024 Hong Kong Deng Yue Med Al Rights